PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.43 Billion | -1.28 Billion | 7.78 Billion | 2.67 Billion | 2.52 Billion | 4.21 Billion |
| Net Income | 5.72 Billion | 89.96 Billion | 41.94 Billion | 11.2 Billion | 404.17 Million | 3.89 Billion |
| Depreciation & Amortization | 4.24 Billion | 3.37 Billion | 3.14 Billion | 2.96 Billion | 2.32 Billion | 1.22 Billion |
| Deferred income taxes | - | - | -47.41 Billion | -8.39 Billion | - | 1.59 Billion |
| Stock-based compensation | - | - | 4.35 Billion | 1.67 Billion | - | 366.63 Million |
| Change in working capital | -6.53 Billion | -12.8 Billion | 4.1 Billion | -4.94 Billion | -808.99 Million | -2.95 Billion |
| Other non-cash items | 1.99 Billion | -81.81 Billion | 1.64 Billion | 174.47 Million | 606.12 Million | 92.86 Million |
| Investing Cash Flow | 3.26 Billion | -15.28 Billion | -30.38 Billion | -7.72 Billion | -10.95 Billion | -9.28 Billion |
| Investments in PPE | -3.29 Billion | -11.95 Billion | -34.01 Billion | -5.46 Billion | -6.78 Billion | -977.61 Million |
| Acquisitions | 80 Million | 190.25 Million | -3 Billion | -550 Million | -23.72 Billion | -2 Billion |
| Investment purchases | -1.5 Billion | -3.5 Billion | -3.21 Billion | -4.5 Billion | -22.08 Billion | -21.75 Billion |
| Sales/Maturities of investments | 7.99 Billion | 2 Million | 4.5 Billion | 4.5 Billion | 41.52 Billion | 15.2 Billion |
| Other Investing Activities | -18.67 Million | -20.37 Million | 5.33 Billion | -1.7 Billion | 111.46 Million | 254.19 Million |
| Financing Cash Flow | 8.85 Billion | 2.26 Billion | 30.34 Billion | 19.56 Billion | -2.58 Billion | 22.29 Billion |
| Debt repayment | -9.1 Billion | -32.63 Billion | -19.75 Billion | -18.82 Million | -16 Billion | -23.09 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -12.4 Million | -5.76 Million | -4.06 Million | - | - | 2.23 Billion |
| Other Financing Activities | 17.96 Billion | 34.91 Billion | 50.09 Billion | 19.58 Billion | 13.41 Billion | 20.08 Billion |
| Accounts receivables | -7.55 Billion | -7.88 Billion | 1.45 Billion | -3.34 Billion | -1.25 Billion | -31.47 Million |
| Accounts payables | -70.56 Million | 433.75 Million | 24.38 Million | 398.26 Million | 2.23 Billion | -2.08 Billion |
| Inventory | 186.9 Million | -5.67 Billion | 1.19 Billion | -2.63 Billion | -1.79 Billion | -67.48 Million |
| Other working capital | 904.77 Million | 322.27 Million | 1.43 Billion | 636.09 Million | 7.71 Million | -2.88 Billion |
| Cash at beginning of period | 19.35 Billion | 33.65 Billion | 25.91 Billion | 11.39 Billion | 22.41 Billion | 5.18 Billion |
| Cash at end of period | 36.9 Billion | 19.35 Billion | 33.65 Billion | 25.91 Billion | 11.39 Billion | 22.41 Billion |
| Capital Expenditure | -3.29 Billion | -11.95 Billion | -34.01 Billion | -5.46 Billion | -6.78 Billion | -977.61 Million |
| Effect of forex changes on cash | - | - | 10.00 | 10.00 | - | - |
| Net cash flow / Change in cash | 17.55 Billion | -14.3 Billion | 7.73 Billion | 14.52 Billion | -11.01 Billion | 17.23 Billion |
| Free Cash Flow | 2.14 Billion | -13.24 Billion | -26.22 Billion | -2.78 Billion | -4.25 Billion | 3.23 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.05 Billion | 1.94 Billion | -321.13 Million | 5.72 Billion | -2.03 Billion | 8.7 Billion |
| Depreciation & Amortization | 1.16 Billion | 1.15 Billion | 1.15 Billion | 4.24 Billion | 1.11 Billion | 1.03 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.43 Billion | -4.67 Billion | -683.92 Million | -6.53 Billion | -2.27 Billion | 123.46 Million |
| Other non-cash items | 2.32 Billion | 5.9 Billion | 4.2 Billion | 1.99 Billion | 2.76 Billion | -7.3 Billion |
| Investing Cash Flow | -406.04 Million | -684.43 Million | -62.07 Million | 3.26 Billion | -744.81 Million | 6.55 Billion |
| Investments in PPE | -267.71 Million | -744.62 Million | -373.39 Million | -3.29 Billion | -492.66 Million | -1.53 Billion |
| Acquisitions | 28.18 Million | - | 35 Million | 80 Million | - | - |
| Investment purchases | - | - | - | -1.5 Billion | - | - |
| Sales/Maturities of investments | - | - | - | 7.99 Billion | - | - |
| Other Investing Activities | -138.33 Million | 60.18 Million | 276.32 Million | -18.67 Million | -252.15 Million | 8.09 Billion |
| Financing Cash Flow | -142.59 Million | -113.41 Million | -2.23 Billion | 8.85 Billion | -138.31 Million | 11.35 Billion |
| Debt repayment | -412.09 Million | - | -2.1 Billion | -9.1 Billion | - | -11.2 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -1.34 Million | -9.45 Million | -12.4 Million | -2.36 Million | -588.84 Thousand |
| Other Financing Activities | 269.5 Million | -1.34 Million | -129.22 Million | 17.96 Billion | -135.94 Million | 22.56 Billion |
| Accounts receivables | -2.31 Billion | -1.87 Billion | -4.92 Billion | -7.55 Billion | -1.95 Billion | 1.9 Billion |
| Accounts payables | 1.47 Billion | 520.81 Million | -1.72 Billion | -70.56 Million | -2.04 Billion | 3.16 Billion |
| Inventory | -2.97 Billion | -885.77 Million | 4.26 Billion | 186.9 Million | 716.7 Million | -5.55 Billion |
| Other working capital | -151.26 Million | -2.43 Billion | 1.7 Billion | 904.77 Million | 1 Billion | 614.07 Million |
| Cash at beginning of period | 35.88 Billion | 36.9 Billion | 34.84 Billion | 19.35 Billion | 36.15 Billion | 15.68 Billion |
| Cash at end of period | 34.44 Billion | 35.88 Billion | 36.9 Billion | 36.9 Billion | 34.84 Billion | 36.15 Billion |
| Capital Expenditure | -267.71 Million | -744.62 Million | -373.39 Million | -3.29 Billion | -492.66 Million | -1.53 Billion |
| Effect of forex changes on cash | - | - | - | - | -10.00 | 10.00 |
| Net cash flow / Change in cash | -1.44 Billion | -1.02 Billion | 2.05 Billion | 17.55 Billion | -1.31 Billion | 20.47 Billion |
| Free Cash Flow | -1.16 Billion | -970.98 Million | 3.98 Billion | 2.14 Billion | -921.92 Million | 1.02 Billion |
CNUTF
8362
LCE
118000
DS
GGBXF